Indivior Pharmaceuticals (INDV) Current Assets (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Current Assets of $667.0 million for Q1 2026, down 24.46% year-over-year from $883.0 million in Q1 2025, and up 2.3% quarter-over-quarter from $652.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Current Assets (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Current Assets history runs 6 years deep, the most recent figure standing at $667.0 million for Q1 2026.
- In Q1 2026, Current Assets fell 24.46% year-over-year to $667.0 million; the TTM figure through Mar 2026 stood at $667.0 million (down 24.46% YoY), while the FY2025 annual figure was $652.0 million, down 21.16% from the prior year.
- Current Assets for Q1 2026 stood at $667.0 million, up from $652.0 million in the prior quarter.
- The five-year high for Current Assets was $1.3 billion in Q4 2022, with the low at $652.0 million in Q4 2025.
- The 5-year median for Current Assets is $902.5 million (2025), against an average of $927.2 million.
- The sharpest annual moves came in 2023 and 2024: Current Assets declined 0.16% in 2023, then plunged 34.21% in 2024.
- Indivior Pharmaceuticals' Current Assets stood at $1.3 billion in 2022, then declined by 0.16% to $1.3 billion in 2023, then slumped by 34.21% to $827.0 million in 2024, then dropped by 21.16% to $652.0 million in 2025, then increased by 2.3% to $667.0 million in 2026.
- Business Quant data shows INDV's Current Assets at $667.0 million in Q1 2026, $652.0 million in Q4 2025, and $922.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 3.22 Bn |
| 10 | Indivior Pharmaceuticals | 4.58 Bn | 4.36 Bn | 294.00 Mn | 725.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 725.00 Mn |
| Mar 31, 2026 | 667.00 Mn |
| Dec 31, 2025 | 652.00 Mn |
| Sep 30, 2025 | 922.00 Mn |
| Jun 30, 2025 | 951.00 Mn |
| Mar 31, 2025 | 883.00 Mn |
| Dec 31, 2024 | 827.00 Mn |
| Dec 31, 2023 | 1.26 Bn |
| Dec 31, 2022 | 1.26 Bn |
| Dec 31, 2021 | 1.44 Bn |